An Evernorth analysis estimates that biosimilar competition can deliver $225 billion to $375 billion in drug cost savings for plan sponsors by 2031. Learn strategies to capture these savings, while preserving choice and flexibility for providers and patients.

Health plans that address and manage complex chronic conditions such as cardiovascular disease, obesity, and diabetes have a competitive advantage.

The way women experience health and disease are unique through specific stages like pregnancy, menopause and more.

A well-designed fertility benefit helps members stay on treatment, reducing wasted dollars

Working with the complex drug supply chain in the United States, PBMs like Express Scripts help drive competition to lower costs and combat the high price of prescription medications. In doing so, we are saving money for employers, health plans, government entities, and the health systems that hire us.

In this episode of the Health Unscripted Podcast, Matt Perlberg, president of the Evernorth Health Services pharmacy businesses, sits down with Vicki Wheeler, chief operating officer of Evernorth's pharmacy businesses, to discuss the current state of specialty drugs in America.